Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Haematology > Multiple Myeloma > Flashcards

Multiple Myeloma Flashcards

1
Q

Haemapoietic stem cell seperates into what?

A

Lymphoid and myeloid stem cell, NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lymphoid stem cell gives us what

A

T and B lymphocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Myeloid stem cells give us what

A

Eryhtrocyte
Platelets
Mast cell
Eosinophil
Polymorph
monocyte
osteoclast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Different types of leukaemia

A

Acute myeloid leukaemia
Acute lymphoblastic leukaemia
Chronic myeloid leukaemia
Chronic lymphocytic leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute leukaemia

A

– primitive early cells – high proliferative rate – chemo targets cell in division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chronic leukaemia

A

lower proliferative rate – insensitive to chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a myeloma?

A

Bone marrow cancer
Cancer of differentiated B-lymphocytes, known as plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a multiple myeloma?

A

is where the myeloma affects multiple areas of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Features of multiple myelomas

A
  • The accumulation of malignant plasma cells in the bone marrow leading to progressive bone marrow failure
  • The production of a characteristic paraprotein
  • Kidney failure
  • Destructive bone disease and hypercalcaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are multiple myelomas assosciated with?

A

devastating osteolytic bone disease charcterised by:
Osteoporosis
Pepper pot skull
Punch through lesions
Mechanisms include an increase in bone resorption, decrease in bone formation and an uncoupling of resorption and formation leading to rapid bone loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pneumonic for melanoma signs and symptoms?

A

SPIKEY OLD CRAB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

C

A

Calcium
Ca>0.25mmol/l above upper limit of normal or >2.75mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

R

A

Renal
renal impairment, creatinine>173mmol
Pathogenesis and treatment of renal failiure in multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A

A

– anaemia
2g <NR or <10g/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

B

A

Bone
lytic lesions, osteoporosis compression, spinal cord compression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Problem with myeloma

A

myeloma remains almost always incurable; it is a remitting, relapsing condition which inexorably progresses to refractory disease and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Multiple myeloma incidence

A

10% of all haematological cancers; overall, the second commonest haematological cancer after non-Hodgkins lymphoma

incidence 60-70 per million; approx 4,000 new cases of myeloma per anum in the UK
Median age diagnosis 70 years
Survival ranges from few months to 20 years sometimes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Monoclonal gammopathy of undetermined significance (MGUS)

A

<30g/dl, <10% plasma cells in the bone marrow, no related organ or tissue impairment (ROTI), no evidence of amyloid or other lymphoproliferative disorder (LPD)

an excess of a single type of antibody or antibody components without other features of myeloma or cancer.
often an incidental finding in an otherwise healthy person - significance unclear.
It may progress to myeloma and patients are often followed up routinely to monitor for progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Smouldering myeloma

A

> 30g/l and/or >10% plasma cells in BM, but no ROTI
20% risk per year of progression in first year, then diminishes to about 5% per year after 5 years and then stabilises

progression of MGUS with higher levels of antibodies or antibody components.
premalignant and more likely to progress to myeloma than MGUS.
Waldenstrom’s macroglobulinemia is a type of smouldering myeloma where there is excessive IgM specifically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Symptomatic myeloma

A

diagnostic criteria as evidence of related organ or tissue impairment (ROTI) or amyloid

21
Q

Is MGUS common?

A

Yes
present in 3% people aged 50, 5% aged 70 – 1% risk per year of progression; majority of cases of MM present de novo but now recognised that most have had a preceding MGUS phase

22
Q

Pathophysiology of myeloma

A

accumulation of malignancy plasma cells in the bone marrow> production of paraprotein [increased amount of plasma protein]> increased proteinuria [protein in urine]> renal disease + destruction bone disease

23
Q

Pathophysiology of myeloma and antibodies:

A

When you measure the immunoglobulins in a patient with myeloma, one of those types will be significantly abundant.
This single type of antibody that is produced by all the identical cancerous plasma cells can be called a monoclonal paraprotein. This means a single type of abnormal protein.

24
Q

How does the destructive bone disease happen?

A

increased plasma cells 🡪 osteoclasts 🡪 increased bone degraded

25
Q

Signs and symptoms of multiple myeloma:

A

hypercalcaemia
tiredness
malaise
increased susceptibility to fractures
opportunistic infections. CRAB

26
Q

Investigations for myelomas:

A

Urine electrophoresis
Serum electrophoresis - IgG or IgA
BM aspirate + trephine biopsy
FBC - low WBC
Imaging - whole body MRI, xray

27
Q

Types of antibodies:

A

IgG, IgA, IgD, IgM, IgE

GAYMED

28
Q

Features of antibodies:

A

antibodies have 2 heavy chains & 2 light chains [kappa & lambda] therefore myeloma are classified by the type of light & heavy chain produced [some people only have light chain myelomas]

29
Q

Treatment approach of multiple myelomas:

A

Diagnosis:
1. Asymptomatic myeloma > regular monitoring
2. Symptomatic myeloma > Candidate for stem cell transplant > Yes: Induction treatment, stem cell transplant/ No: non-intensive drug treatment

30
Q

What is bone marrow infiltration?

A

cancerous plasma cells invade the bone marrow.

31
Q

How does bone marrow infiltration cause anaemia?

A

causes suppression of the development of other blood cell lines leading to anaemia (low red cells), neutropenia (low neutrophils) and thrombocytopenia (low platelets). PANCYTOPENIA

32
Q

What do osteoclasts do?

A

Osteoclasts absorb bone

33
Q

What do osteoblasts do?

A

osteoblasts deposit bone

34
Q

What happens in myeloma bone disease?

A

result of increased osteoclast activity and suppressed osteoblast activity.

caused by cytokines released from the plasma cells and the stromal cells (other bone cells) when they are in contact with the plasma cells.

35
Q

What are the common places for bone disease to happen?

A

skull, spine, long bones and ribs

36
Q

What are osteolytic lesions?

A

in some areas the bone becomes very thin whereas others remain relatively normal.

these weak points in bone lead to pathological fractures

37
Q

Hypercalcaemia in myeloma

A

All the osteoclast activity causes a lot of calcium to be reabsorbed from the bone into the blood. This results in hypercalcaemia (high blood calcium).

38
Q

Plasmacytomas

A

These are individual tumours made up of the cancerous plasma cells.

They can occur in the bones, replacing normal bone tissue or can occur outside bones in the soft tissue of the body.

39
Q

Why do we get renal impairment in myelomas?

A

High levels of immunoglobulins (antibodies) can block the flow through the tubules

Hypercalcaemia impairs renal function

Medications used to treat the conditions such as bisphosphonates can be harmful to the kidneys

40
Q

Why is plasma viscosity higher in myelomas?

A

Plasma viscosity increases when there are more proteins in the blood.

These are proteins like immunoglobulins and fibrinogen, both of which increase with inflammation.

In myeloma there are large amounts of immunoglobulins in the blood causing the plasma viscosity to be significantly higher.

41
Q

What issues does plasma viscosity cause?

A
  • Easy bruising
  • Easy bleeding
  • Reduced or loss of sight due to vascular disease in the eye
  • purplish palmar erythema
  • Heart failure
42
Q

Risk factors

A

Older age
Male
Black African ethnicity
Family history
Obesity

43
Q

Suspecting myeloma

A

FBC (low white blood cell count in myeloma)
Calcium (raised in myeloma)
ESR (raised in myeloma)
Plasma viscosity (raised in myeloma)

If any of these are positive or myeloma is still suspected do an urgent serum protein electrophoresis and a urine Bence-Jones protein test.

44
Q

Myeloma testing (BLIP)

A

B – Bence–Jones protein (request urine electrophoresis)
L – Serum‑free Light‑chain assay
I – Serum Immunoglobulins
P – Serum Protein electrophoresis

Bone marrow biopsy is necessary to confirm the diagnosis of myeloma and get more information on the disease.

45
Q

Imaging for bone lesions:

A

1.Whole body MRI
2.Whole body CT
3.Skeletal survey (xray images of the full skeleton)

Patients only require one investigation but may not tolerate or be suitable for MRI or CT.

46
Q

X-ray signs

A

Punched out lesions
Lytic lesions
“Raindrop skull” caused by many punched out (lytic) lesions throughout the skull that give the appearance of raindrops splashing on a surface

47
Q

First line treatment:

A

First line treatment usually involves a combination of chemotherapy with:

Bortezomid
Thalidomide
Dexamethasone

48
Q

When can stem cell transplantation be used?

A

can be used as part of a clinical trial where patients are suitable.

Patients require venous thromboembolism prophylaxis with aspirin or low molecular weight heparin whilst on certain chemotherapy regimes (e.g. thialidomide) as there is a higher risk of developing a thrombus.

49
Q

Management of myeloma bone disease:

A

Myeloma bone disease can be improved using bisphosphonates. These suppress osteoclast activity.

Radiotherapy to bone lesions can improve bone pain.

Orthopaedic surgery can stabilise bones (e.g. by inserting a prophylactic intramedullary rod) or treat fractures.

Cement augmentation involves injecting cement into vertebral fractures or lesions and can improve spine stability and pain

Haematology (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions